Variable | Number of patients | % |
---|---|---|
All patients | 123 | 100 |
Age (years) | Â | Â |
   ≤45 | 49 | 40 |
   >45 | 74 | 60 |
ER status | Â | Â |
   Positive | 75 | 61 |
   Negative | 48 | 39 |
PR status | Â | Â |
   Positive | 74 | 60 |
   Negative | 49 | 40 |
HER2 status | Â | Â |
   Positive | 41 | 33 |
   Negative | 82 | 67 |
T stage | Â | Â |
   1 | 60 | 49 |
   2 | 49 | 40 |
   3 | 10 | 8 |
   4 | 4 | 3 |
N stage | Â | Â |
   0 | 63 | 51 |
   1 | 29 | 24 |
   2 | 18 | 15 |
   3 | 13 | 11 |
M stage | Â | Â |
   0 | 114 | 93 |
   1 | 9 | 7 |
Chemotherapy | Â | Â |
   No | 19 | 15 |
   Yes | 104 | 85 |
Hormone receptor targeting therapy | Â | |
   No | 34 | 28 |
   Yes | 89 | 72 |
Radiation therapy | Â | Â |
   No | 50 | 41 |
   Yes | 73 | 59 |
Herceptin | Â | Â |
   No | 102 | 83 |
   Yes | 21 | 17 |